Oocyte
5
1
2
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
6 treatments under study, led by Ganirelix
Research Leaders
7 sponsors active, led by Centrum Clinic IVF Center
Related Conditions
Often studied with 16 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 5 trials
100.0%
+13.4% vs benchmark
40%
2 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (5)
Improvement of Live Babies Rates After ICSI, Using cpFT
To Investigate the Relationship Between the Viscoelastic Properties of the Zona Pellucida of Human Oocyte and the Blastocyst Utilization Rate
Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A.
MVA to Improve the Pregnancy Outcome in Aged Infertility Women With Assisted Reproductive Technology
Effect of Follicular Flushing in Patients With Mono-follicular Growth Undergoing In Vitro Fertilization
Research Network
Common Treatments
- Ganirelix1
- Direct Follicular Aspiration1
- Follicular Flushing1
- Cyclic Peptide Fertiline1
- Medroxyprogesterone Acetate1
Active Sponsors
- Centrum Clinic IVF Center1
- Inti Labs1
- Theramex1
- Ginefiv1
- Assistance Publique - Hôpitaux de Paris1
Top Investigators
Centrum Clinic IVF Center
Center for Reproductive Medicine and Obstetrics and Gynecology, Drum Tower Hospital, Nanjing University Medical School
AP-HP, Hospital Cochin
Related Conditions
- Invitro Fertilization1
- Zona Pellucida1
- Female Infertility1
- Infertility1
- Pregnancy1